Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. Moderna, Inc.
  6. News
  7. Summary
    MRNA   US60770K1079

MODERNA, INC.

(MRNA)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Moderna : Piper Sandler Upgrades Moderna to Overweight From Neutral

10/15/2021 | 07:09am EST


ę MT Newswires 2021
All news about MODERNA, INC.
12:21aModerna CEO says vaccines likely less effective against Omicron - FT
RE
12:21aMODERNA CEO SAYS VACCINE EFFECTIVENESS WILL LIKELY DROP AGAINST OMICRON VARIANT - FT In..
RE
11/29U.S. administers 459.2 mln doses of COVID-19 vaccines - CDC
RE
11/29Health Care Up As Moderna Surges On Vaccine Anticipation -- Health Care Roundup
DJ
11/29SCIENTISTS SCRAMBLE TO UNDERSTAND CO : What we know
AQ
11/29Wall Street rebounds after virus-related sell-off
RE
11/29US Stocks Rebound Monday After Friday's Sell-Off as Megacap Techs Lead
MT
11/29U.S. CDC says all adults should get COVID-19 booster shots
RE
11/29New variant cause for concern, not panic, Biden tells US
AQ
11/29U.S. CDC says all adults 18 and over should get COVID-19 booster shots
RE
More news
Analyst Recommendations on MODERNA, INC.
More recommendations
Financials (USD)
Sales 2021 17 449 M - -
Net income 2021 11 169 M - -
Net cash 2021 12 344 M - -
P/E ratio 2021 14,0x
Yield 2021 -
Capitalization 149 B 149 B -
EV / Sales 2021 7,86x
EV / Sales 2022 6,16x
Nbr of Employees 1 300
Free-Float 90,5%
Chart MODERNA, INC.
Duration : Period :
Moderna, Inc. Technical Analysis Chart | MRNA | US60770K1079 | MarketScreener
Technical analysis trends MODERNA, INC.
Short TermMid-TermLong Term
TrendsBullishNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 18
Last Close Price 368,51 $
Average target price 272,53 $
Spread / Average Target -26,0%
EPS Revisions
Managers and Directors
StÚphane Bancel Chief Executive Officer & Director
Stephen Hoge President
David W. Meline Chief Financial Officer
Noubar B. Afeyan Chairman
Juan Andres Chief Technical Operations & Quality Officer
Sector and Competitors
1st jan.Capi. (M$)
MODERNA, INC.252.74%149 412
LONZA GROUP AG29.85%59 443
IQVIA HOLDINGS INC.46.26%50 064
SEAGEN INC.-3.22%30 994
CELLTRION, INC.-40.81%24 431
ALNYLAM PHARMACEUTICALS, INC.45.06%22 548